Zobrazeno 1 - 10
of 53
pro vyhledávání: '"B, Kirchheiner"'
Autor:
B, KIRCHHEINER
Publikováno v:
Acta Medica Scandinavica. 168:223-234
Autor:
B, Lund, R B, Andersen, J, Fossgreen, P, Holm, E M, Jensen, B, Kirchheiner, J, Kryger, J, Pichard
Publikováno v:
European journal of rheumatology and inflammation. 9(2)
The long-acting antiphlogistics tenoxicam (Ro 12-0068, Tilcotil) and piroxicam in single daily oral doses of 20 mg are compared in a double-blind, group-comparative, randomised trial planned to last for five years. Results of 12 months' treatment of
Publikováno v:
Scandinavian journal of rheumatology. Supplement. 1976
In a double-blind cross-over trial the clinical efficacy of ketoprofen (19.583 R.P., Orudis, Profenid N.D.), in comparison with that of indomethacin was investigated in 30 patients with rheumatoid arthritis. The two drugs were each given in a dosage
Publikováno v:
International journal of clinical pharmacology and biopharmacy. 13(4)
Diclophenac sodium, Voltaren, has been tested against indomethacin and placebo in a four-week double-blind between-patient trial in 182 patients with rheumatoid arhritis. The ameliorating effect of Voltaren on the usual clinical parameters was compar
Autor:
B, Kirchheiner, J, Egeberg
Publikováno v:
Acta morphologica Neerlando-Scandinavica. 6(4)
Autor:
B, Kirchheiner, G G, Rasmussen
Publikováno v:
Ugeskrift for laeger. 132(28)
Autor:
B, Kirchheiner, A, Marckmann
Publikováno v:
Acta rheumatologica Scandinavica. 11(3)
Autor:
B, Kirchheiner, O, Pedersen-Bjergaard
Publikováno v:
Scandinavian journal of rehabilitation medicine. 5(3)
Autor:
B, Kirchheiner
Publikováno v:
Ugeskrift for laeger. 131(41)
Publikováno v:
Acta pharmacologica et toxicologica. 32(6)
Twentyfour patients with rheumatoid arthritis (A.R.A. criteria) were examined before and after a period of gold treatment (10–33 weeks). The Rheumatoid Activity Index (according to Lansbury 1958) decreased significantly (mean ± S. D.: −33.2 ± 2